Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Microsoft
MSFT
|
$7.54B |
| 2 |
Apple
AAPL
|
$5.11B |
| 3 |
Amazon
AMZN
|
$2.93B |
| 4 |
UnitedHealth
UNH
|
$2.83B |
| 5 |
Alphabet (Google) Class C
GOOG
|
$2.75B |
Top Sells
| 1 |
ZEN
ZENDESK INC
ZEN
|
$330M |
| 2 |
Snap
SNAP
|
$321M |
| 3 |
Twilio
TWLO
|
$309M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$156M |
| 5 |
AVLR
Avalara, Inc.
AVLR
|
$154M |
Sector Composition
| 1 | Technology | 29.71% |
| 2 | Healthcare | 21.23% |
| 3 | Financials | 11.2% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AQUA
276
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $154M | 0.06% |
4,659,304
+2,273,305
| +95% | +$75.2M |
|
277
Quest Diagnostics
DGX
$20.4B
| $154M | 0.06% |
1,255,898
+605,383
| +93% | +$74.3M |
|
278
Envista
NVST
$3.49B
| $152M | 0.06% |
4,646,702
+1,501,810
| +48% | +$49.3M |
|
279
Lincoln Electric
LECO
$13.4B
| $152M | 0.06% |
1,210,278
+495,957
| +69% | +$62.4M |
|
280
Legend Biotech
LEGN
$6.49B
| $152M | 0.06% |
3,724,748
+3,633,649
| +3,989% | +$148M |
|
|
SUM
281
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $152M | 0.06% |
6,439,825
+3,221,121
| +100% | +$75.9M |
|
282
Saia
SAIA
$8.22B
| $151M | 0.06% |
795,180
+396,082
| +99% | +$75.3M |
|
|
GBT
283
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $149M | 0.06% |
2,190,686
-2,287,562
| -51% | -$156M |
|
284
Wendy's
WEN
$1.92B
| $149M | 0.06% |
7,969,072
+4,241,324
| +114% | +$79.3M |
|
285
Insmed
INSM
$31B
| $147M | 0.06% |
6,842,652
-157,685
| -2% | -$3.4M |
|
|
SRC
286
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $144M | 0.05% |
3,988,020
+1,631,583
| +69% | +$59M |
|
287
Gates Industrial
GTES
$6.59B
| $144M | 0.05% |
14,731,682
+7,187,552
| +95% | +$70.2M |
|
288
Crown Castle
CCI
$40B
| $144M | 0.05% |
993,040
+469,260
| +90% | +$67.9M |
|
289
Seres Therapeutics
MCRB
$190M
| $143M | 0.05% |
1,116,325
+847,805
| +316% | +$109M |
|
|
MYOV
290
DELISTED
Myovant Sciences Ltd.
MYOV
| $142M | 0.05% |
7,907,682
+2,458,575
| +45% | +$44.2M |
|
291
Bio-Techne
TECH
$8.35B
| $142M | 0.05% |
1,993,304
+996,060
| +100% | +$70.7M |
|
|
ALTR
292
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $142M | 0.05% |
3,200,024
+1,600,217
| +100% | +$70.8M |
|
293
National Vision
EYE
$1.84B
| $141M | 0.05% |
4,333,604
+2,165,058
| +100% | +$70.7M |
|
294
CubeSmart
CUBE
$9.32B
| $140M | 0.05% |
3,497,554
+1,427,734
| +69% | +$57.3M |
|
295
Leslie's
LESL
$63.3M
| $140M | 0.05% |
9,516,270
+4,903,756
| +106% | +$72.1M |
|
296
Zebra Technologies
ZBRA
$15.9B
| $137M | 0.05% |
522,118
+328,356
| +169% | +$86.1M |
|
297
GATX Corp
GATX
$5.93B
| $136M | 0.05% |
1,593,000
+789,286
| +98% | +$67.2M |
|
298
BWX Technologies
BWXT
$15.1B
| $136M | 0.05% |
2,691,720
+981,063
| +57% | +$49.4M |
|
299
Jabil
JBL
$22.6B
| $135M | 0.05% |
2,346,382
+1,289,784
| +122% | +$74.4M |
|
|
ENV
300
DELISTED
ENVESTNET, INC.
ENV
| $135M | 0.05% |
3,048,900
+1,280,276
| +72% | +$56.8M |
|